Celecoxib in arthritis: relative risk management profile and implications for patients
Gayle McKellar1, Gurkirpal Singh21Centre for Rheumatic Diseases, Glasgow Royal Infirmary, Glasgow, UK; 2Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, CA, USAAbstract: Celecoxib is a selective cyclo-oxygenase 2 inhibitor licensed for use in musculoske...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Dove Medical Press,
2009-11-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|